In the quest for optimal gastric cancer surgery, a study of 11,173 patients in the US compared robotic and laparoscopic gastrectomy. The analysis revealed that robotic gastrectomy (RG) outshone laparoscopic gastrectomy (LG) in terms of adequate lymphadenectomy, negative margins, shorter hospital stay, lower mortality, and superior 5-year overall survival. Propensity score matching affirmed RG’s superiority […]
Category: General Surgery
Robotic Surgery Revolution: 3D Drawing Annotations Enhance Telementoring
In a groundbreaking study, researchers explored the effectiveness of telementoring in robotic surgery with 3D drawing annotations. Conducted 140 km apart, the study used the Saroa™ surgical robot, evaluating 20 medical students. The 3D annotation group demonstrated potential for shorter working time, fewer retries, and needle drops compared to the control. Notably, they outperformed in […]
Rare Hemorrhage After Distal Pancreatectomy
In the post-distal pancreatectomy (DP) landscape, researchers explored the rare territory of clinically relevant post-pancreatectomy hemorrhage (CR-PPH). Among 1,188 patients, 5.5% encountered CR-PPH, marked by increased 90-day mortality and morbidity. Prolonged operative time and co-existing postoperative pancreatic fistula independently heightened CR-PPH risk. Strikingly, the failure-to-rescue rate was significantly higher in CR-PPH cases, emphasizing the gravity […]
Pancreatic Cancer Diagnosis: FDG-PET/CT Ratio Signals Malignancy in Branch-Duct IPMNs
In the realm of pancreatic branch-duct intraductal papillary mucinous neoplasms (bd-IPMNs), spotting malignancy is tricky. However, researchers delving into 58 cases discovered a game-changer. The standardized uptake value (SUV) from FDG-PET/CT, specifically the tumor-to-blood pool ratio (TBR), emerged as a potent indicator of malignancy. Correlating significantly with histopathology, TBR proved independently significant in scenarios defining […]
Preventing Obstruction: Identifying Risk Criteria for Colon Cancer Patients Undergoing Neoadjuvant Chemotherapy
In the FOxTROT trial, analyzing high-risk colon cancer patients undergoing neoadjuvant chemotherapy (NAC), researchers identified pre-treatment risk criteria to stratify obstruction risk. Among 699 patients, 4.3% developed obstruction. Two independent criteria, obstructing disease on endoscopy or inability to pass through the tumor, and stricturing disease on radiology or endoscopy, were associated with higher risk. This […]
Enhancing Training for Surgical Oncology Excellence
Complex General Surgical Oncology (CGSO) fellowship graduates, while generally feeling prepared for practice, expressed concerns about research and specific clinical areas like thoracic, hyperthermic intraperitoneal chemotherapy (HIPEC), and hepato-pancreato-biliary surgery. The study reveals potential gaps between trainee expectations and surgical oncology practice realities, suggesting opportunities to refine the training model. Improvements, such as increased autonomy, […]
Navigating Neoadjuvant Uncertainty: Ampullary and Duodenal Adenocarcinoma Management
The study delves into the uncertain territory of neoadjuvant therapy (NAT) for ampullary (AA) and duodenal adenocarcinoma (DA). Analyzing 15 retrospective studies, no clear survival differences were found between NAT and upfront surgery. While some studies hinted at benefits like increased pathologic response, overall evidence supporting NAT for AA and DA is weak. The research […]
Social Vulnerability Delays Treatment: Impact on Primary Hyperparathyroidism Evaluation
In a Massachusetts study on primary hyperparathyroidism, researchers found that patients in socially vulnerable groups faced delays in surgeon evaluation, contributing to heightened risks of long-term complications. Among 1,082 patients, those in the highest vulnerability quartile had a 33% lower surgeon evaluation rate and were seen 67 days later than those in the lowest quartile. […]
Remote Ischemic Preconditioning Falls Short in Liver Protection Post-Hepatectomy
In a randomized trial involving 102 patients with chronic liver disease undergoing hepatectomy, remote ischemic preconditioning’s anticipated liver-protective benefits were not realized. Despite inducing preconditioning through upper extremity cycles of ischemia and reperfusion, the study showed no significant reduction in postoperative transaminase levels. The results suggest limited efficacy in mitigating ischemia-reperfusion injury, challenging the application […]
Prophylactic Mesh Fails to Halt Long-Term Parastomal Hernias
In a comprehensive review of eight randomized trials with 537 patients, the long-term efficacy of prophylactic mesh during end colostomy creation was debunked. Contrary to prior expectations, the incidence of parastomal hernia showed no significant reduction, challenging the strategy’s effectiveness. Both parastomal hernia repair rates and mortality remained comparable between mesh and non-mesh groups, with […]